| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.61▼ | 1.59▼ | 1.59▼ | 1.58▼ | 1.78▼ |
| MA10 | 1.61▼ | 1.61▼ | 1.61▼ | 1.62▼ | 2.22▼ |
| MA20 | 1.63▼ | 1.71▼ | 1.71▼ | 1.83▼ | 3.26▼ |
| MA50 | 2.00▼ | 2.08▼ | 2.09▼ | 2.49▼ | 4.19▼ |
| MA100 | 2.27▼ | 2.40▼ | 2.46▼ | 3.44▼ | N/A |
| MA200 | 2.70▼ | 3.11▼ | 3.33▼ | 4.16▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.009▲ | 0.010▲ | 0.018▲ | -0.174▼ |
| RSI | 36.061▼ | 35.216▼ | 35.261▼ | 28.509▼ | 20.163▼ |
| STOCH | 39.115 | 27.865 | 27.865 | 21.295 | 5.765▼ |
| WILL %R | -82.353▼ | -88.462▼ | -88.462▼ | -90.552▼ | -97.400▼ |
| CCI | -117.685▼ | -106.816▼ | -106.816▼ | -89.150 | -99.281 |
|
Wednesday, September 09, 2026 04:00 AM
Positive safety and favourable biodistribution seen in all subjects dosed Imaging data in all evaluable pancreatic cancer patients demonstrated significant tumor uptake Data support the targeting ...
|
|
Wednesday, August 26, 2026 12:01 AM
SYDNEY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative ...
|
|
Monday, August 03, 2026 12:14 PM
Radiopharm Theranostics (NASDAQ: RADX) released its Quarterly Activities and Cash Report for its fourth quarter and fiscal year ending June 30 th, 2026. Beyond the review of cash sources and uses for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/09/26 | 1.54 | 1.60 | 1.47 | 1.52 | 42,886 |
| 28/09/26 | 1.60 | 1.80 | 1.52 | 1.52 | 43,967 |
| 25/09/26 | 1.57 | 1.68 | 1.4407 | 1.65 | 37,572 |
| 24/09/26 | 1.61 | 1.68 | 1.485 | 1.5719 | 58,935 |
| 23/09/26 | 1.65 | 1.6899 | 1.49 | 1.625 | 35,679 |
| 22/09/26 | 1.69 | 1.69 | 1.50 | 1.65 | 33,365 |
| 21/09/26 | 1.73 | 1.75 | 1.60 | 1.61 | 35,818 |
| 18/09/26 | 1.74 | 1.8415 | 1.65 | 1.65 | 36,778 |
| 17/09/26 | 1.70 | 1.91 | 1.70 | 1.73 | 66,435 |
| 16/09/26 | 1.56 | 1.80 | 1.55 | 1.67 | 169,384 |
|
|
||||
|
|
||||
|
|